Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
As for Klotho analysis ELISA kit, Immuno-Biological Laboratories were mostly used (50%), followed by Cusabio (27.78%).Characteristics of the included studies.First author (year)CountryStudy designAge (year)Sample sizeCharacteristics of populationAffected arteryOutcomesCorrelation coefficient (r), p valueOdds ratio/Beta coefficient with confidence intervalAdjusted factorsClinical measurement method for arterial calcification, thickness, or stiffnessSampleLaboratory measurement method for FGF-23 or KlothoSalam et al. (2021)40UK, EuropeCross sectional62 ± 1269Advanced CKDLower leg arteryCorrelation between FGF-23 and LLAC0.397, p = 0.001: : HRpQCTSerumManual ELISA (Immutopics)Yilmaz et al. (2015)55Turkey, AsiaCross sectional32 ± 9178Renal transplants (stage 5 CKD)CarotidCorrelation between FGF-23 and CIMT0.36, p = 0.001: : Doppler ultrasoundSerumSecond generation, two-site mAb ELISA (Kainos laboratories)Craver et al. (2013)68Spain, EuropeCross sectionalCAC 75 ± 6Non-CAC 61 ± 1453 AAC, 57 no AACStage 3 and 4 CKDAbdominal aortaComparison of FGF-23 and Klotho levels between groups with/without arterial calcification: : : Kauppila index from lateral lumbar X raysSerumELISA for C-Term (Immutopics for FGF-23 and Immuno-Biological Laboratories for Klotho)Masai et al. (2013)49Japan, AsiaCross sectional65.5 (55 to 72)148Suspected CADCoronaryCorrelation between FGF-23 and Agatston score0.169, p = 0.039Beta 1.488 (0.448; 2.529)Sex, age, CKD stage, carotid plaque, FEPAgatston score from CTSerumSandwich ELISA (Kainos laboratories)Nitta et al. (2018)30Japan, AsiaCross sectionalCalcification: 71.8 ± 10.4No calcification: 60.7 ± 14.0101 calcification, 173 no calcificationMHDAortic archCorrelation between FGF-23 and AoACS score− 0.12, p = 0.0175Beta − 0.120 (− 0.220 to − 0.021)Age, gender, BMI, dialysis vintage, Kt/V, CaxP, Hb, albumin, sclerostinChest X raysSerumSandwich ELISA (Kainos laboratories)Nasrallah et al. (2010)39Egypt, AfricaCross sectional50 ± 11.565HDAbdominal aortaCorrelation between FGF-23 and aortic calcification index0.48, p = 0.0001Beta 0.58 (0.001 to 0.002)Age, dialysis vintage, diastolic blood pressure, parathormone, phosphate, triglycerides, cholesterolCT of abdominal aortaSerumTwo side ELISA (Immutopics)Lee et al. (2016)48Taiwan, AsiaCross sectional63.0 ± 10.1227MHDAbdominal aortaCorrelation between FGF-23 and abdominal aortic calcification; comparison of FGF-23 levels between groups with/without arterial calcification0.116, p = 0.019Beta 1.940 (0. 614 to 3.267)Age, BMI, diabetes, hypertension, vascular disease, calcium, calcium phosphate products, albumin, hsCRP, sclerostin, DKK-1,Kauppila index from lateral lumbar X raysSerumELISA (Immutopics)Ibrahim et al. (2018)59Egypt, AfricaCross sectional43 ± 14.2128HDUnspecifiedCorrelation between FGF-23 and PWV: : : Doppler with 2D guidance and ECG triggerSerumSandwich ELISA (Diagnostics Systems Laboratories)Castelblanco et al. (2022)88Spain, EuropeCross sectional52.2 ± 8.8 with plaque, 41.9 ± 10.3 no plaque85 with plaque, 288 no plaqueType 1 DMCarotidComparison of FGF-23 and Klotho levels between groups with/without subclinical carotid atherosclerosis: : : CIMT from Carotid Ultrasound ImagingSerumELISA (TECOmedical for FGF-23 and Cusabio Biotech for α-klotho)Sandoval et al. (2015)82Mexico, AmericaCross sectional50 ± 16 calcification, 41 ± 18 no calcification22 calcification, 54 no/low calcificationPeritoneal dialysisUnspecifiedComparison of FGF-23 levels between groups with/without arterial calcification: : : Adragao Score from plain radiographic films of pelvis and handsSerumLuminex/Magpix systemFayed et al. (2019)46Egypt, AfricaCross sectional43.68 ± 13.6681Recently starting HDAbdominal aortaCorrelation between FGF-23 and abdominal aortic calcification0.8, p < 0.001: : Abdominal CTSerumELISA (unspecified)Pencak et al. (2013)80Poland, EuropeCross sectional60 (57 to 63)76 AAC + CAC, 10 no calcificationHDAbdominal aorta and coronaryComparison of FGF-23 levels between groups with/without arterial calcification: : : Agatston score from CTPlasmaELISA (Immutopics)Srivaths et al. (2014)83US, AmericaCross sectional19.7 ± 1.5 CAC, 16.2 ± 3.2 no CAC6 CAC, 10 no CACPediatric HDCoronaryComparison of FGF-23 levels between groups with/without arterial calcification: : : Agatston score from CTSerumELISA (Immutopics)Milovanova et al. (2022)37Russia, EuropeCross sectional20: 65130CKDCoronaryCorrelation between Klotho and abdominal CCS/ PWVKlotho: CCS: − 0.581, p < 0.01; Klotho: PWV: − 0.66, p < 0.001: : CCS EchocardiographySerumELISA (Merck Millipore for FGF-23 and Immuno-Biological Laboratories for Klotho)Yu et al. (2018)67China, AsiaCross sectional63.43 ± 12.76330HDCarotidCorrelation between Klotho and CIMT− 0.183, p = 0.001: : Doppler ultrasoundSerumELISA (Immuno-Biological Laboratories)Cianciolo et al. (2010)45Italy, EuropeCross sectionalMales 62.5 ± 13.5, females 60.5 ± 11.5253ESRDCoronaryCorrelation between FGF-23 and CAC, comparison of FGF-23 levels between groups with/without arterial calcification− 0.23, p = 0.02: : Agatston score from CTPlasmaELISA (Immutopics)Muzasti et al. (2021)50Indonesia, AsiaCross sectional57 (25 to 78)75HDAbdominal aortaCorrelation between FGF-23 and AAC0.543, p < 0.001: : Lateral lumbar X raysSerumTwo-site ELISA (unspecified)Baralic et al. (2019)69Serbia, EuropeCross sectional54 ± 1356HDIliac, femoral, radial and digital arteriesAssociation between FGF-23 and vascular score: OR 1.006 (0.992 to 1.012): Adragao score from radiographic films of pelvis and handsSerumELISA (Cusabio)He et al. (2017)90China, AsiaCross sectionalLEAD: 62 (59 to 68)No LEAD: 50 (41 to 58)201 LEAD, 200 no LEADType 2 DMLower extremities arteriesComparison of FGF-23 levels between groups with/without lower extremities arterial thickness: : : Doppler ultrasoundSerumELISA (Kainos)Ford et al. (2011)58UK, EuropeCross sectional69 ± 11200Stage 3 and 4 CKDAortaCorrelation between FGF-23 and PWV0.262, p < 0.001: : CompliorSerumSandwich ELISA (Immutopics)Mudi et al. (2019)53South Africa, AfricaCross sectional10.8 ± 3.572CKD childrenCarotidCorrelation between FGF-23 and CIMT0.222, p = 0.061: : Doppler ultrasoundPlasmaELISA (Merck Millipore)Ortiz et al. (2020)54Spain, EuropeCross sectional59.5 ± 0.3939Non-CKD CHDCarotidCorrelation between FGF-23 and CIMT0.16, p < 0.001: : Doppler ultrasoundSerumELISA (Kainos)Koga et al. (2021)61Japan, AsiaCross sectional68 ± 975Stable CHDCoronaryCorrelation between Klotho and CAC− 0.31, p = 0.007: : Intravascular ultrasoundSerumELISA (Immuno-Biological Laboratories)Balci et al. (2010)87Turkey, AsiaCross sectional55.5 ± 13128MHDCarotidComparison of FGF-23 levels between groups with/without arterial thickness: : : Doppler ultrasoundPlasmaELISA for C-Term (Immutopics)Bundy et al. (2018)70US, AmericaCross sectionalCAC 60.6 ± 9.3, no CAC 50.9 ± 12.2689 CAC, 434 no CACMild to moderate CKDCoronaryComparison of FGF-23 levels between groups with/without CAC: OR 1.32 (1.05 to 1.67)Age, sex, race/ethnicity, clinical site, follow-up time between CT scans, total cholesterol, HDL cholesterol, systolic BP, use of antihypertensive medications, diabetes, current smoking, history of CVD, use of statin medications, and physical activityAgatston score from CTSerumELISA for C-Term (Immutopics)Cai et al. (2015)60China, AsiaCross sectional58.18 ± 13.72129MHDAbdominal aortaCorrelation between Klotho and AAC− 0.214, p = 0.015: Age, gender, smokingKauppila index from abdominal aorta plain roentgenographySerumSandwich ELISA (Immuno-Biological Laboratories)Keles et al. (2016)65Turkey, AsiaCross sectional33 (29 to 40)80Type 1 DMCarotidCorrelation between Klotho and CIMT− 0.594, p = 0.001: : UltrasoundSerumELISA (Cusabio Biotech)Chen et al. (2013)24China, AsiaCross sectional55.1 ± 14.9120MHDAbdominal aortaCorrelation between FGF-23 and AAC0.371, p < 0.001OR 2.366 (1.304 to 4.291)PTHLateral lumbar X raysPlasmaELISA for C-Term (Immutopics)Coban et al. (2018)51Turkey, AsiaCross sectional47.8 ± 13.986Autosomal Dominant Polycystic Kidney DiseaseCarotidCorrelation between FGF-23 and PWV/CIMTFGF-23: PWV: 0.337, p = 0.002; FGF-23: CIMT: 0.298, p = 0.005: : UltrasoundSerumELISA (Elabscience)Jasani et al. (2018)77India, AsiaCross sectional48.5 ± 12.860 CAC, 40 no CACHDCoronaryComparison of FGF-23 levels between groups with/without CAC: : : Agatston score from CTSerumELISA (Immutopics)Jeong et al. (2013)63South Korea, AsiaCross sectional47.2 ± 8.1 with subclinical carotid atherosclerosis, 38.5 ± 8.1 without subclinical carotid atherosclerosis140HIVCarotidCorrelation between Klotho and CIMT, comparison of Klotho levels between groups with/without subclinical carotid atherosclerosis− 0.258, p = 0.004OR 0.006 (0.000 to 0.677)Age, HIV, total cholesterol, gender, stavudine useUltrasoundPlasmaSandwich ELISA (Immuno-Biological Laboratories)Villodres et al. (2019)84Spain, EuropeCross sectional58 ± 845 AAC, 35 no AACStage 3 CKDAbdominal aortaComparison of FGF-23 and Klotho levels between groups with/without AAC: : : Agatston score from abdominal CTSerumDirect sandwich ELISA (Kainos for FGF-23 and Cusabio for Klotho)Keles et al. (2015)64Turkey, AsiaCross sectional32 (27 to 38)50Healthy adultsCarotidCorrelation between Klotho and CIMT− 0.522, p < 0.001: : UltrasoundSerumELISA (Cusabio Biotech)Figurek et al. (2018)52Bosnia, EuropeCross sectional62.86 ± 11.4387CKDCarotidCorrelation between FGF-23 and CIMT0.12, p > 0.05: : UltrasoundSerumELISA (Elabscience)Morita et al. (2015)31Japan, AsiaCross sectionalMen 67 ± 11.6, women 68.5 ± 11.5157Subjects diagnosed or suspected with CADCoronary and aortic valveCorrelation between FGF-23/ Klotho and Agatston scoreFGF-23: Agatston score: 0.244, p = 0.035; Klotho: Agatston score: − 0.058, p = 0.621OR FGF-23: CAC 2.39 (0.73 to 7.88); OR FGF-23: AVC 1.73 (0.57 to 5.2)Age, CKD stage, hypertension, statin, diuretics, cCa, P, PTH, and vitamin DAgatston score from CTSerumELISA (Kainos for FGF-23 and Immunobiological Laboratories for Klotho)Nakayama et al. (2013)72Japan, AsiaCross sectional71.9 ± 9.4 CAC, 62.7 ± 12.3 no CAC54 CAC, 34 no CACNon-HD CKDCarotidComparison of FGF-23 levels between groups with/without carotid calcification: OR 1.75 (1.01 to 3.04)Age, sex, hypertension, DM, smoking, dyslipidemia, BMI, proteinuria, CRP, Hb, P, Ca-P, eGFRAgatston score from CTSerumELISA (Kainos)Schoppet et al. (2012)73France, EuropeCross sectional72 ± 7780Healthy adultsAbdominal aortaAssociation between FGF-23 and abdominal aortic calcification: OR 1.25 (1.03 to 1.53)Age, weight, ischemic heart disease, hypertension, diabetes mellitus, and vitamin DDual-energy X-ray absorptiometrySerumELISA (Immutopics)Singh et al. (2022)29India, AsiaCross sectional10.159CKD childrenCarotidCorrelation between FGF-23 and CIMT/PWVFGF-23: CIMT: − 0.195, NS; FGF-23: PWV: 0.183, NS: : UltrasoundSerumELISA (Elabscience)Zeng et al. (2015)56China, AsiaCross sectional56.19 ± 14.187PDCarotidCorrelation between FGF-23 and CIMT0.628, p < 0.0001: : UltrasoundPlasmaELISA (unspecified)Zhang et al. (2015)43China, AsiaCross sectional56.77 ± 10.41200CKD stage 3 to 5CoronaryCorrelation between FGF-23 and CAC0.177, p = 0.034: : Agatston score from CTSerumTwo-site ELISA (Kainos)Zayed et al. (2015)42Egypt, AfricaCross sectional5280MHDCoronaryCorrelation between FGF-23 and CAC0.7, p = 0.001: : Agatston score from CTSerumTwo-site ELISA (Immutopics)El Baz et al. (2017)25Egypt, AfricaCross sectional55.8 ± 9.4 calcification, 52.5 ± 9.1 no calcification60ESRDCoronary and abdominal aortaCorrelation between FGF-23 and CAC/AAC, comparison of FGF-23 levels between groups with/without arterial calcificationFGF: CAC: 0.682, p < 0.001; FGF: AAC: 0.606, p < 0.001: : Agatston score from CTPlasmaNot specifiedZaki et al. (2018)41Egypt, AfricaCross sectional18: 7090HDAbdominal aortaCorrelation between FGF-23 and aortic calcification0.964, p < 0.001: : CTSerumELISA (unspecified)Tarigan et al. (2019)66Indonesia, AsiaCross sectional54.21 ± 10.8670MHDCarotidCorrelation between Klotho and CIMT− 0.368. p = 0.002: : UltrasoundPlasmaELISA (Bio Vendor)Gutierrez et al. (2009)71US, AmericaCross sectional≧30162Predialysis CKDCoronaryAssociation between FGF-23 and CAC: OR 1.2 (0.8 to 1.7): Agatston score from CTSerumTwo-site ELISA (Immutopics)Lin et al. (2022)62China, AsiaCross sectional52.15 ± 8.898MHDAbdominal aorta, iliac, femoral, radial, and digital arteriesCorrelation between Klotho and arterial calcification− 0.72, p < 0.0001: : Plain radiographic imagesSerumELISA (R&D Systems)Turan et al. (2016)44Turkey, AsiaCross sectional58.7 ± 14.2229HDCoronary arteryCorrelation between FGF-23 and arterial calcificationr = 0.218, p = 0.001: : Agatston score from CTPlasmaELISA (Immutopics)Zhu (2023)75China, AsiaCross sectional55.8 ± 14.958 CAC, 70 no CACNon-HD CKDCoronary arteryComparison of FGF-23 between groups with/without CAC, association between FGF-23 and CAC: OR 0.896 (0.257 to 3.118)Age, DM, vitamin D, C1q/tumor necrosis factor-related protein-3Agatston score from CTSerumELISA (Elabscience)Cancela (2012)85Brazil, South AmericaCross sectional58.1 ± 9.3169 CAC, 121 no CACSuspected CAD with normal renal functionCoronary arteryComparison of FGF-23 between groups with/without CAC: : : Agatston score from CTSerumELISA (Kainos)Zamparini (2018)57South Africa, AfricaCross sectional29.8 ± 13.6 patient group, 28.8 ± 13.01 control groups30 patient group, 30 control groupFamilial hypercholesterolemiaCarotid arteryCorrelation between FGF-23 and CIMTr = − 0.2656, p > 0.05: : UltrasoundSerumELISA (Kainos)Guo et al. (2021)89China, AsiaCase control68.85 ± 7.45 with plaque, 46.62 ± 5.51 no plaque40 with plaque, 33 no plaqueCAPDCarotidComparison of FGF-23 and Klotho levels between groups with/without carotid artery thickness: : : CIMT from Carotid Ultrasound ImagingSerumELISA (Millipore)Ge et al. (2022)76China, AsiaCohort53.61 ± 11.72 calcification, 39.76 ± 10.30 no calcification38 CAC, 25 no CACMHDCoronaryComparison of FGF-23 levels between groups with/without arterial calcification: : : Agatston score from Coronary CTPlasmaELISA for C-Term (Immutopics)Petrauskiene et al. (2018)81Lithuania, EuropeCohort65.2 ± 14.4 calcification, 53.97 ± 16.2 no calcification50 calcification, 31 no calcificationHDUnspecifiedComparison of FGF-23 levels between groups with/without arterial calcification: : : Adragao Score from plain radiographic films of pelvis and handsSerumELISA (Sunlong Biotech)Bortnick et al. (2019)86US, AmericaCohort70 ± 8 AVC, 61 ± 10 no AVC913 AVC, 5899 no AVCMulti ethnic non-CVDAortic valveComparison of FGF-23 levels between groups with/without arterial calcification: : : Agatston score from Coronary CTSerumELISA (Kainos)Di Lullo et al. (2015)38Italy, EuropeCohort51 (46 to 56)100Mild to moderate CKDAortic valveCorrelation between Klotho and AVC− 0.208, p = 0.04Coef Beta 0.116 (0.048 to 0.183)PTHEchocardiographySerumELISA for C-Term (Biocompare Laboratories)Krishnasamy et al. (2017)47Australia, AustraliaCohort≧1840Advanced CKDAbdominal aortaCorrelation between FGF-23/ Klotho and AACFGF-23: AAC: 0.5, p < 0.001; Klotho: AAC: − 0.36, p = 0.002OR FGF-23 and AAC 2.61 (1.41 to 6.98)Age, diabetes, hypertension, eGFR, corrected calcium, phosphate, and vitamin DLateral lumbar X raysSerumELISA (Kainos for FGF-23 and Immuno-Biological Laboratories for KlothoKurnatowska et al. (2011)78Poland, EuropeCohort62.3 ± 10.9 CAC, 53.1 ± 1.0 no CAC33 CAC, 14 no CACHDCoronaryComparison of FGF-23 levels between groups with/without CAC: : : Agatston score from CTPlasmaELISA (ALPCO Diagnostics)Linefsky et al. (2014)79US, AmericaCohort70.49 ± 8.1 AVC, 60.86 ± 9.9 no AVC913 AVC, 5899 no AVCMulti ethnic studyAortic valveComparison of FGF-23 levels between groups with/without AVC: : : Agatston score from CTSerumSandwich ELISA (Kainos)Zhu et al. (2019)74China, AsiaCohort60.19 ± 12.15 no to minor calcification, 55.02 ± 14.20 moderate to severe calcification61 no to minor calcification, 53 moderate to severe calcificationHDAbdominal aortaComparison of FGF-23 levels between groups with/without abdominal aortic calcification: OR 2.83 (1.01 to 7.94)Age, dialysis vintage, smoking, logFGF23, Kt/v, hsCRP, HDL, iPTH, and calcitriol useKauppila index from lateral abdominal radiographsSerumELISA (Kainos)Zheng et al. (2018)26China, AsiaCohort61.91 ± 15.39128MHDCoronaryCorrelation between Klotho and CAC− 0.667, p = 0.001: : Agatston score from CTSerumELISA (R&D)Buiten et al. (2014)103Netherlands, EuropeCohort67 ± 7127HDCoronary and abdominal aortaAssociation between Klotho and AAC/CAC: Beta Klotho AAC: 0.58 (− 0.07 to 1.22); CAC: 0.08 (− 0.19 to 0.36)Age, gender, dialysis vintage, dialysis type, and residual renal functionAgatston score from CT for CAC, lateral abdominal X rays for AACPlasmaELISA (Immuno-Biological Laboratories)Scialla et al. (2013)27US, AmericaCohort57 ± 123939Mild to moderate CKDCoronaryAssociation between FGF-23 and CAC/TAC: OR CAC 1.02 (0.90 to 1.16); TAC 1.06 (0.93 to 1.21)Age, sex, race, ethnicity, eGFR, ln-transformed urine albumin-to-creatinine ratio, prior cardiovascular, disease, DM, hypertension, hypercholesterolemia, smoking, BMI, corrected serum calcium, PTH, and clinical centerAgatston score from CTPlasmaSecond generation C-terminal assay (Immutopics)AAC abdominal aortic calcification, AoACS aortic arch calcification score, AVC aortic valve calcification, BMI body mass index, Ca calcium, CAC coronary artery calcification, CAD coronary artery disease, CAPD continuous ambulatory peritoneal dialysis, CCS cardiac calcification score, CHD coronary heart disease, CKD chronic kidney disease, CT computed tomography, CVD cardiovascular disease, DKK-1 Dickkopf-1, DM diabetes mellitus, eGFR estimated glomerular filtration rate, ELISA enzyme-linked immunoassay, ESRD end stage renal disease, FEP fractional excretion of phosphate, Hb hemoglobin, HRpQCT High resolution peripheral quantitative computed tomography, hsCRP high-sensitivity C-reactive protein, LEAD lower extremity atherosclerotic disease, LLAC lower leg arterial calcification, MHD maintenance hemodialysis, NS not significant, P phosphate, PD peritoneal dialysis, PTH parathyroid hormone, PWV pulse wave velocity.
Source: Study characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies
Review / evidence synthesis · Scientific Reports · 2024
Original publication title
Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies
© The Author(s) 2024
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
This meta-analysis was conducted to clarify the role of klotho and fibroblast growth factor 23 (FGF-23) in human arterial remodeling across recent studies, in terms of arterial calcification, thickness, and stiffness. A systematic literature search was conducted on five databases for articles up to December 2023. Arterial calcification, thickness, and stiffness were determined using the calcification score and artery affected, carotid intima: media thickness (CIMT), and pulse wave velocity (PWV), respectively. Sixty-two studies with a total of 27,459 individuals were included in this meta-analysis.
Most studies involved chronic kidney disease patients. Study designs were mostly cross-sectional with only one case: control and nine cohorts. FGF-23 was positively correlated with arterial calcification (r = 0.446 [0.254 to 0.611], p < 0.0001 and aOR = 1.36 [1.09 to 1.69], p = 0.006), CIMT (r = 0.188 [0.02 to 0.354], p = 0.03), and PWV (r = 0.235 [0.159 to 0.310], p < 0.00001). By contrast, Klotho was inversely correlated with arterial calcification (r = − 0.388 [− 0.578 to − 0.159], p = 0.001) and CIMT (r = − 0.38 [− 0.53 to − 0.207], p < 0.00001).
In conclusion, FGF-23 and Klotho were associated with arterial calcification, thickness, and stiffness, clarifying their role in arterial remodeling processes.
Authors’ abstract
This meta-analysis was conducted to clarify the role of klotho and fibroblast growth factor 23 (FGF-23) in human arterial remodeling across recent studies, in terms of arterial calcification, thickness, and stiffness. A systematic literature search was conducted on five databases for articles up to December 2023. Arterial calcification, thickness, and stiffness were determined using the calcification score and artery affected, carotid intima: media thickness (CIMT), and pulse wave velocity (PWV), respectively. Sixty-two studies with a total of 27,459 individuals were included in this meta-analysis.
Most studies involved chronic kidney disease patients. Study designs were mostly cross-sectional with only one case: control and nine cohorts. FGF-23 was positively correlated with arterial calcification (r = 0.446 [0.254 to 0.611], p < 0.0001 and aOR = 1.36 [1.09 to 1.69], p = 0.006), CIMT (r = 0.188 [0.02 to 0.354], p = 0.03), and PWV (r = 0.235 [0.159 to 0.310], p < 0.00001). By contrast, Klotho was inversely correlated with arterial calcification (r = − 0.388 [− 0.578 to − 0.159], p = 0.001) and CIMT (r = − 0.38 [− 0.53 to − 0.207], p < 0.00001).
In conclusion, FGF-23 and Klotho were associated with arterial calcification, thickness, and stiffness, clarifying their role in arterial remodeling processes.
Publication and source details
Original title: Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies
Citrawati Dyah Kencono Wungu; Hendri Susilo; Mochamad Yusuf Alsagaff; Bendix Samarta Witarto; Andro Pramana Witarto; Cennikon Pakpahan; Arief Gusnanto
Scientific Reports · 2024
© The Author(s) 2024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T12:41:51.176159+00:00
DOI: 10.1038/s41598-024-56377-8 · PMC10923819